Literature DB >> 24185591

Plasma citrulline as a biomarker for enterocyte integrity in pediatric blood and BMT.

J B Karlik1, A Kesavan2, M L Nieder3, R Hawks4, Z Jin5, M Bhatia4, E J Ladas4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24185591     DOI： 10.1038/bmt.2013.165

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Authors:  Ludy C H W Lutgens; Nicole M A Blijlevens; Nicolaas E P Deutz; J Peter Donnelly; Philippe Lambin; Ben E de Pauw
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

2.  Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population.

Authors:  N Lepage; N McDonald; L Dallaire; M Lambert
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

3.  Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.

Authors:  Ludy C H W Lutgens; Nicolaas Deutz; Marlies Granzier-Peeters; Regina Beets-Tan; Dirk De Ruysscher; John Gueulette; Jack Cleutjens; Martijn Berger; Bradly Wouters; Maarten von Meyenfeldt; Philippe Lambin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

4.  Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy.

Authors:  A H Herbers; T Feuth; J P Donnelly; N M Blijlevens
Journal:  Ann Oncol       Date:  2010-01-20       Impact factor: 32.976

5.  Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients.

Authors:  A H E Herbers; N M A Blijlevens; J P Donnelly; T J M de Witte
Journal:  Bone Marrow Transplant       Date:  2008-06-30       Impact factor: 5.483

6.  Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT.

Authors:  W J F M van der Velden; A H E Herbers; R J M Brüggemann; T Feuth; J Peter Donnelly; N M A Blijlevens
Journal:  Bone Marrow Transplant       Date:  2013-01-21       Impact factor: 5.483

7.  Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy.

Authors:  N M A Blijlevens; L C H W Lutgens; A V M B Schattenberg; J P Donnelly
Journal:  Bone Marrow Transplant       Date:  2004-08       Impact factor: 5.483

8.  Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.

Authors:  Michel J van Vliet; Wim J E Tissing; Edmond H H M Rings; Harma A Koetse; Frans Stellaard; Willem A Kamps; Eveline S J M de Bont
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

Review 9.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 10.  Citrulline and the gut.

Authors:  Emmanuel Curis; Pascal Crenn; Luc Cynober
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-09       Impact factor: 4.294
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.